PHAXIAM Therapeutics S.A. Adjustments For Share-based Payments
PHAXIAM Therapeutics S.A. reported Adjustments For Share-based Payments of EUR 390.00 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2023-09-26
| Period end | Adjustments For Share-based Payments 6 month | Adjustments For Share-based Payments 12 month |
|---|---|---|
| 2023-06-30 | 390.00K EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 447.00K EUR 20-F · filed 2023-03-28 | |
| 2022-06-30 | 326.00K EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 1.32M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 707.00K EUR 6-K · filed 2022-09-12 | |
| 2020-12-31 | 1.18M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 384.00K EUR 6-K · filed 2021-09-20 | |
| 2019-12-31 | 1.36M EUR 20-F · filed 2022-04-27 | |
| 2019-06-30 | 749.00K EUR 6-K · filed 2020-09-21 | |
| 2018-12-31 | 2.45M EUR 20-F · filed 2021-03-08 | |
| 2018-06-30 | 1.38M EUR 6-K · filed 2019-09-26 | |
| 2017-12-31 | 1.77M EUR 20-F · filed 2020-03-18 | |
| 2016-12-31 | 1.18M EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | 2.72M EUR 20-F/A · filed 2018-05-23 |